Literature DB >> 3899426

Ultrastructural analysis of peripheral blood mononuclear cells in renal allograft recipients.

P Musiani, F B Aiello, F Citterio, N Maggiano, L M Larocca, M Piantelli.   

Abstract

Renal transplanted patients receiving immunosuppressive therapy with glucocorticoids (GC) and azathioprine show in the peripheral blood numerous large mononuclear cells. The origin and the lineage of these cells was not clearly established. In the present study we investigated the surface phenotype and the ultrastructural characteristics of this subset constituted by large mononuclear cells. From peripheral blood mononuclear cells (PBL) of allograft recipients, a cell preparation exhaustively depleted of the relatively numerous monocytes was obtained. At ultrastructural examination two main cellular populations were distinguished: the predominant one (congruent to 85%) was constituted by cells with lymphoid morphology while the other (congruent to 15%) showed myeloid appearance. The large lymphoid cells, T4 or T8 positive, did not express Ia molecules on the surface and were morphologically suggestive of cells in an intermediate stage of the cell cycle between resting and activated lymphocytes. The myeloid population was constituted by promyelocytes, myelocytes and metamyelocytes. Promyelocytes and myelocytes capable of cell division are responsible for the increase of 3H-thymidine incorporation observed in transplanted patient PBL. In conclusion our data suggest that in allograft recipients the immunosuppressive therapy with GC and azathioprine may inhibit the lymphocyte blast transformation and can influence the release of immature myeloid cells responsible for the PBL increased 3H-thymidine incorporation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899426      PMCID: PMC1577227     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Differential effects of immunosuppressive drugs on human T, B, and K lymphocytes.

Authors:  F Thomas; J Thomas; G Mendez; R Lower; H M Lee
Journal:  Transplantation       Date:  1977-12       Impact factor: 4.939

2.  Peripheral blood leucocyte changes during human renal allograft rejection.

Authors:  J R Parker; J F Mowbray
Journal:  Transplantation       Date:  1971-03       Impact factor: 4.939

3.  Collection of lymph from kidneys homotransplanted in man: cell transformation in vivo.

Authors:  J Hamburger; A Dimitriu; L Bankir; M Debray-Sachs; J Auvert
Journal:  Nature       Date:  1971-08-27       Impact factor: 49.962

4.  Alteration of the cell periphery during granulocyte maturation: relationship to cell function.

Authors:  M A Lichtman; R I Weed
Journal:  Blood       Date:  1972-03       Impact factor: 22.113

5.  Prednisolone-induced granulocytosis.

Authors:  J J Cream
Journal:  Br J Haematol       Date:  1968-09       Impact factor: 6.998

6.  Lymphocyte activation: a rapid test to predict allograft rejection.

Authors:  E M Hersh; W T Butler; R D Rossen; R O Morgen
Journal:  Nature       Date:  1970-05-23       Impact factor: 49.962

7.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

8.  The effect of in vivo hydrocortisone on subpopulations of human lymphocytes.

Authors:  A S Fauci; D C Dale
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

Review 9.  Glucocorticosteroid therapy: mechanisms of action and clinical considerations.

Authors:  A S Fauci; D C Dale; J E Balow
Journal:  Ann Intern Med       Date:  1976-03       Impact factor: 25.391

10.  The role of the lymphatic system in the rejection of homografts: a study of lymph from renal transplants.

Authors:  N C Pedersen; B Morris
Journal:  J Exp Med       Date:  1970-05-01       Impact factor: 14.307

View more
  1 in total

1.  Phenotypic change of human cultured meningioma cells.

Authors:  R Pallini; P Casalbore; D Mercanti; N Maggiano; L M Larocca
Journal:  J Neurooncol       Date:  2000-08       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.